BU Well
Volume 3 Health, Wellness, and Life Sciences

Articles and Multimedia

2018

A Shocking Solution: Electroconvulsive Therapy and its Effects on
Depression and Other Mental Illnesses
Victoria Cook
Butler University

Follow this and additional works at: https://digitalcommons.butler.edu/buwell
Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons

Recommended Citation
Cook V. A Shocking Solution: Electroconvulsive Therapy and its Effects on Depression and Other Mental
Illnesses. BU Well. 2018; 3(1).

This Articles and Multimedia is brought to you for free and open access by the Undergraduate Scholarship at
Digital Commons @ Butler University. It has been accepted for inclusion in BU Well by an authorized editor of
Digital Commons @ Butler University. For more information, please contact digitalscholarship@butler.edu.

A Shocking Solution: Electroconvulsive Therapy and its Effects on
Depression and Other Mental Illnesses
Victoria Cook

Abstract: Mental illness and its treatments continue to be demanding topics requiring the attention of the healthcare community. While
pharmaceutical treatments increase in popularity, many people remain unaware of the non-pharmacological options available. One of the
available unconventional treatment methods includes electroconvulsive shock therapy, a technique that utilizes bouts of electricity to
stimulate anti-depressive behaviors. Although its methods have been disputed for a long time, electroconvulsive shock therapy is a longstanding and effective treatment for depression. Electroconvulsive shock therapy has a dense history which has led to the stigmatization
of it as a treatment, and it has credible downsides. Electroconvulsive shock therapy has been proven to work and its use can be promoted
via further research on the topic.

D

epression is the leading cause of disability worldwide and is
recognized as one of the major contributors to the global
burden of disease.1 Historically, society casted the treatment of
mental illnesses in a negative light. However, with an increase in
the recognition of mental illness as a true obstacle to wellness
the stigma surrounding mental illness begins to slowly fade. The
focus has shifted away from acknowledgement and towards
treatment. Prescription drugs are commonly viewed as the sole
agent in combating mental illness. However, there are many
other novel therapies posing as potential treatments. One of the
most notable therapeutic options is electroconvulsive therapy
(ECT), which essentially shocks a patient into good health. While
shocking a person into an epileptic episode may appear barbaric
and better suited for a low-budget horror film, there has been a
surprising number of successful cases where these convulsions
alleviate the symptoms of mental illness, particularly
depression.2 Despite the success of ECT, several less desirable
effects merit hesitation.3 Perhaps even more intriguing than the
effects of ECT, are the mechanisms by which electricity helps
relieve depression. Successful treatments certainly warrant
curiosity, but the treatment’s scarcity in healthcare is largely
unjustified and based on stigma rather than evidence-based
results. Overall, ECT deserves more attention both in clinical and
research settings within the medical field.

HISTORY
The mistreatment of the mentally ill reached its peak in
the 19th century with a surge in the number of mental asylums.
Fear of mental illness was spurred on by the growth of populations caused by the Industrial Age and was transformed into the
imprisonment of those who suffered from mental illnesses.4
Luckily, scientists and other specialists searched for innovative
solutions to the conditions now known as schizophrenia and depression. In trials ran by Manfred Sankel in 1927, insulin was
used to treat schizophrenia by inducing seizure activity in the
patient. Unfortunately, the success did not last, and most

patients returned to their pre-treatment state.5 In 1934, metrazol, a drug that caused similar convulsive episodes, was introduced.5 These metrazol-induced seizures eventually became the
main inspiration behind the first ECT techniques, introduced by
Ugo Cerlatti in 1938.2 The trials leading up to Cerlatti’s established convulsions of the body could improve a patient’s mental
state, but his new techniques allowed ECT to surpass its predecessors as a suitable treatment.5 Metrazol failed to gain traction
as a treatment for mental disease due to the lack of instantaneous loss of consciousness which was achieved with Cerlatti’s ECT.
Within a few successful treatments, Cerlatti’s ECT had proved to
be a safer and more popular way to improve mental illness than
metrazol.5 Within months, Cerlatti and his team recognized ECT’s
ability to alleviate symptoms of depression better than
schizophrenia, its targeted illness.2 Soon, ECT was on track to
become a promising medical treatment for depression.

THE FACTS
Today, ECT is most often used in patients who suffer
from major depression with resistance to pharmaceutical drugs.
Patients prescribed ECT for depression may also come to the
clinic with symptoms of catatonia, a state of immobility; mania,
a state of abnormally heightened mood; or lethargy. ECT,
introduced to battle depression in the 1930s, is still considered
the most successful treatment for severe depression with
efficacy rates of 80-90%.6,7 Professionals regard the widespread
evidence supporting ECT treatment as among the strongest for
any medical treatment, due to the large amount of data
collected since the first ECT treatment in the 19th century.7 ECT
is also highly recommended for patients who have recently
expressed suicidal thoughts and behavior because it is proven
to work quicker than antidepressants.6,8
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WHY AND HOW DOES IT WORK?
Although ECT is not a new development in the
treatment of mental illness, the mechanisms behind ECT are still
unclear. Several theories continue to develop as research
advances. Discovering the mechanisms of ECT dates to Sigmund
Freud, the first to report a connection between psychological
conditions and biological processes in the brain and nervous
system. This contrasted with the psychological theory of that
time in which mental illness was linked to personality and early
childhood experiences.5 Many doctors assumed a defective
nervous system led to mental illness, which pushed them to
research treatments that included electrically stimulating patient
brains.4 Another key discovery during the early days of ECT was
the “biological antagonism” between epilepsy and mental
disease, specifically schizophrenia.5 Because those suffering
from seizures did not typically suffer from mental disease,
researchers like Cerlatti induced seizures in patients to cure their
mental disease.2
To understand how ECT works, researchers focused on
changes in the brain after ECT sessions. Current research
indicates an increase in both neurogenesis and cell proliferation
in the brain after electroconvulsive seizures.6 Neurogenesis is the
production of new neurons. This process slows under stress and
drug abuse, which are commonly seen in conjunction with
depression.9 While neurogenesis appears to counteract the
effects of stress, recent studies have also indicated increases in
neurogenesis after brain trauma.10 Cell proliferation, or growth,
occurs alongside neurogenesis in the same portion of the brain
and
counteracts
depression-like
symptoms.
Unlike
neurogenesis, cell growth drops dramatically after about two
weeks post-ECT, aligning with the patient’s relapse back to his
or her depressed state. Due to the coincidental timing of
patients halting cell growth and returning to their depressed
state, researchers propose the effectiveness of ECT in patients
with depression and its lack of long-lasting effects are due to the
seizure’s stimulation of cell proliferation.6
Another theory for the explanation of how ECT works
notes how ECT increases levels of glutamate and GABA, two
chemicals essential for brain function.9 Low levels of glutamate
and GABA are typically found in individuals with depression.
Therefore, ECT appears to alleviate symptoms of depression by
affecting the activity of these two chemicals. Similar to
neurogenesis and cell proliferation, increases in glutamate and
GABA levels are linked to head trauma. Most people would find
the correlation between trauma and ECT alarming, but the
processes may serve as recuperative functions for the brain.9 The
lack of an adopted mechanism of action for ECT necessitates
further research.

WHY THE BAD REPUTATION?
With widespread evidence supporting the effectiveness
of ECT in treating mental diseases, a person is left to wonder why
ECT is a less popular treatment option than the drugs found on

pharmacy shelves. Several reasons exist for the incongruity. To
start, ECT’s treatment method is slightly frightening and
exacerbated by negative stereotypes portrayed in the media.6 To
make matters worse, the history of ECT did not proceed in a
righteous manner. Psychiatric wards arrived with the growth of
cities in the 1900s and were known to sedate unruly patients
with a form of ECT. Then in the 1970s, a new wave of protests
against the institutionalization of mentally ill patients portrayed
both the institutions and ECT treatments in a negative shadow.5
While abuse was present in these institutions, the unethical and
inappropriate use of ECT treatment should not have dismissed
its effectiveness.
Conflicting reports about ECT’s effectiveness have
surfaced over the years, but these can be mostly attributed to its
inappropriate application. ECT was used for a wide range of
mental disorders, even when the patients did not improve.6 The
overuse of ECT made the treatment appear less effective, further
discrediting it. Using electricity to cure a disease may not appear
logical or safe, but with the correct application and regulation, it
can be effective.

CREDIBLE DOWNSIDES
Similar to prescription drugs used to treat mental
illnesses, ECT has notable side effects. One of the major side
effects, which has produced the most concern from medical
professionals and patients, is the potential for memory loss. In
every ECT case, the patient loses consciousness as soon as the
first shock is administered.6 Then, the patient wakes up after the
treatment with slight confusion, a headache, and little
recollection of the course of the treatment.8 While lack of
memory of the actual treatment is an attraction of ECT for many
patients,2 memory loss can extend as far as six months before
the treatment and two months after the treatment.8 However,
there are techniques to reduce the negative effect on memory.
If the procedure is performed with electrodes placed on only one
side of the skull rather than on both sides, adverse effects on
memory may be prevented.3 Any patient considering ECT should
reflect on the potential for memory loss, but also acknowledge
the potential side effects in other treatment options, like
prescribed antidepressants.
Unlike memory loss, which has proven to be a
legitimate concern, other adverse effects of ECT have largely
been reduced with proper technique and regulation. In the early
days of ECT treatment, fractures and dislocations did occur
infrequently,2 but these risks have been “virtually eliminated”
since the 1980s. Death is another possibility but the chances of
death occurring are similar to barbiturate anesthesia use, which
is a common technique used within medical practices.8
Another common critique of ECT is the high rate of
relapse of patients back to their original state. ECT is not a cure.
Therefore, when treatments stop, the positive effects typically
stop as well. A recent study showed 84% of patients who did not
receive any further treatment in the six months after their last
ECT session relapsed into their previous state. ECT is not viewed
as a long-term treatment and the patient is usually given
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antidepressants to prevent relapse, a combination that has
proven to be successful. In fact, the same study mentioned
earlier revealed only 39% of patients relapsed when the ECT
treatment was followed by nortriptyline and lithium. While longterm ECT, or continuation ECT, is another option, the effects of
the extended treatment plan require more extensive research.11
In comparison, medications used safely and frequently for
extended periods of time also only alleviate symptoms
temporarily.12 Most patients who receive ECT or conventional
pharmaceutical treatment for a mental disorder are susceptible
to relapse.
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CONCLUDING REMARKS
Despite the downsides of ECT and a need for more research, this treatment method can be an incredibly useful tool in
the battle against mental diseases. Although society has largely
rejected its usage, ECT produces significant beneficial effects in
those suffering from depression. In fact, a recent study asked the
parents of teenagers who had undergone ECT about their experience and every parent responded positively. Additionally, none
of the parents thought ECT was worse than other medications, a
stance that opposes popular opinion.13 Unfortunately, many
health centers do not have a policy for safe ECT practice, thus
limiting patient access to ECT.6 As depression and other mental
diseases gain attention and become less stigmatized, so must
their treatments. No matter how uncommon, ECT is a viable
treatment option in the healthcare world’s repertoire of tools to
combat mental illnesses like depression.
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